
Created by: Huber (Project 8) , generated 2006/03/29, last changed: 2008/01/08
Possible groups to be added:
Pharmaceutical companies active in MDS and willing to cooperate with LeukemiaNet
Celgene (http://www.celgene.com/)
Pharmion (http://www.pharmion.com/)
Amgen (http://www.amgen.com/)
Roche (http://www.roche.com/)
Novartis (http://www.novartis.com/)
Apotex (http://www.apotex.com/)
Chugai (http://www.chugai-pharm.co.jp/hc/chugai_top_en.jsp;jsessionid=GYS25FHCKM0XCCSSUIHCFEQ)
CTI
Genzyme, ATG (location Sangstet, Lyon) (http://www.genzyme.com/)
Name of the study group |
Groupe Francais des Myelodysplasies |
Disease(s) |
MDS classified according to FAB or WHO classifications |
Leader(s) of the study group |
Pr Pierre FENAUX |
Website |
|
Studies |
|
Contact persons |
Pr Pierre FENAUX |
Diagnostic Labs |
|
Name of the study group |
The Budapest MDS study group |
Disease(s) |
MDS |
Leader(s) of the study group |
Judit Várkonyi, MD, PhD |
Website |
|
Studies |
metabl. enzyme plymorphism, HFE gene analysis, iron metabolism, copper metabolism studies in MDS |
Contact persons |
See above |
Diagnostic Labs |
Semmelweis University |
Name of the study group |
German MDS-Study Group |
Disease(s) |
MDS |
Leader(s) of the study group |
Prof. Dr. A. Ganser, Prof. Dr. C. Aul |
Website |
|
Studies |
ATG+CSA, 5-Aza-Cytidine, Decitabine, Revlimid, Valproic Acid |
Contact persons |
Prof. Dr. A. Ganser (Ganser.Arnold@mh-hannover.de) |
Diagnostic Labs |
Germing (Düsseldorf) |
Laboratories
Hofmann_Berlin_labinfo.doc
(31KB)